142
Participants
Start Date
October 12, 2021
Primary Completion Date
December 30, 2022
Study Completion Date
December 30, 2022
FX-322
Active Comparator
Placebo
Placebo
Clinical Trial Site, Tucson
Clinical Trial Site, Fresno
Clinical Trial Site, Torrance
Clinical Trial Site, Colorado Springs
Clinical Trial Site, Sarasota
Clinical Trial Site, Tampa
Clinical Trial Site, Marrero
Clinical Trial Site, Novi
Clinical Trial Site, Omaha
Clinical Trial Site, Albany
Clinical Trial Site, Amherst
Clinical Trial Site, New York
Clinical Trial Site, Winston-Salem
Clinical Trial Site, Cincinnati
Clinical Trial Site, Oklahoma City
Clinical Trial Site, Charleston
Clinical Trial Site, Orangeburg
Clinical Trial Site, Spartanburg
Clinical Trial Site, Dallas
Clinical Trial Site, Fort Worth
Clinical Trial Site, San Antonio
Clinical Trial Site, Murray
Clinical Trial Site, St. George
Clinical Trial Site, Norfolk
Clinical Trial Site, Richmond
Clinical Trial Site, Milwaukee
Lead Sponsor
Frequency Therapeutics
INDUSTRY